Literature DB >> 17344795

RTOG 0522: a randomized phase III trial of concurrent accelerated radiation and cisplatin versus concurrent accelerated radiation, cisplatin, and cetuximab [followed by surgery for selected patients] for Stage III and IV head and neck carcinomas.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17344795

Source DB:  PubMed          Journal:  Clin Adv Hematol Oncol        ISSN： 1543-0790


× No keyword cloud information.
  16 in total

1.  Development and Validation of Nomograms Predictive of Overall and Progression-Free Survival in Patients With Oropharyngeal Cancer.

Authors:  Carole Fakhry; Qiang Zhang; Phuc Felix Nguyen-Tân; David I Rosenthal; Randal S Weber; Louise Lambert; Andy M Trotti; William L Barrett; Wade L Thorstad; Christopher U Jones; Sue S Yom; Stuart J Wong; John A Ridge; Shyam S D Rao; James A Bonner; Eric Vigneault; David Raben; Mahesh R Kudrimoti; Jonathan Harris; Quynh-Thu Le; Maura L Gillison
Journal:  J Clin Oncol       Date:  2017-08-04       Impact factor: 44.544

Review 2.  Head and neck cancer: an evolving treatment paradigm.

Authors:  David M Cognetti; Randal S Weber; Stephen Y Lai
Journal:  Cancer       Date:  2008-10-01       Impact factor: 6.860

3.  Human papillomavirus and overall survival after progression of oropharyngeal squamous cell carcinoma.

Authors:  Carole Fakhry; Qiang Zhang; Phuc Felix Nguyen-Tan; David Rosenthal; Adel El-Naggar; Adam S Garden; Denis Soulieres; Andy Trotti; Vilija Avizonis; John Andrew Ridge; Jonathan Harris; Quynh-Thu Le; Maura Gillison
Journal:  J Clin Oncol       Date:  2014-06-23       Impact factor: 44.544

Review 4.  Chemotherapy advances in locally advanced head and neck cancer.

Authors:  Peter Georges; Kumar Rajagopalan; Chady Leon; Priya Singh; Nadir Ahmad; Kamyar Nader; Gregory J Kubicek
Journal:  World J Clin Oncol       Date:  2014-12-10

Review 5.  Folliculitis induced by EGFR inhibitors, preventive and curative efficacy of tetracyclines in the management and incidence rates according to the type of EGFR inhibitor administered: a systematic literature review.

Authors:  Jean-Baptiste Bachet; Lucie Peuvrel; Claude Bachmeyer; Ziad Reguiai; Pierre A Gourraud; Olivier Bouché; Marc Ychou; Rene J Bensadoun; Brigitte Dreno; Thierry André
Journal:  Oncologist       Date:  2012-03-16

6.  Molecular characterization of head and neck cancer: how close to personalized targeted therapy?

Authors:  Maria J Worsham; Haythem Ali; Jadranka Dragovic; Vanessa P Schweitzer
Journal:  Mol Diagn Ther       Date:  2012-08-01       Impact factor: 4.074

Review 7.  Vision 20/20: perspectives on automated image segmentation for radiotherapy.

Authors:  Gregory Sharp; Karl D Fritscher; Vladimir Pekar; Marta Peroni; Nadya Shusharina; Harini Veeraraghavan; Jinzhong Yang
Journal:  Med Phys       Date:  2014-05       Impact factor: 4.071

8.  Effect of brain stem and dorsal vagus complex dosimetry on nausea and vomiting in head and neck intensity-modulated radiation therapy.

Authors:  Katherine Ciura; Michelle McBurney; Baongoc Nguyen; Mary Pham; Neal Rebueno; Clifton D Fuller; Nandita Guha-Thakurta; David I Rosenthal
Journal:  Med Dosim       Date:  2010-01-22       Impact factor: 1.482

Review 9.  Current aspects of targeted therapy in head and neck tumors.

Authors:  Andreas Dietz; Andreas Boehm; Christian Mozet; Gunnar Wichmann; Athanassios Giannis
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-07       Impact factor: 2.503

10.  Phase II study of cetuximab in combination with cisplatin and radiation in unresectable, locally advanced head and neck squamous cell carcinoma: Eastern cooperative oncology group trial E3303.

Authors:  Ann Marie Egloff; Ju-Whei Lee; Corey J Langer; Harry Quon; Alec Vaezi; Jennifer R Grandis; Raja R Seethala; Lin Wang; Dong M Shin; Athanassios Argiris; Donghua Yang; Ranee Mehra; John Andrew Ridge; Urjeet A Patel; Barbara A Burtness; Arlene A Forastiere
Journal:  Clin Cancer Res       Date:  2014-08-08       Impact factor: 12.531
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.